Risk Prediction Score for Pediatric Patients with Suspected Ebola Virus Disease
Alicia E. Genisca1
, Tzu-Chun Chu1
, Lawrence Huang, Monique Gainey, Moyinoluwa Adeniji, Eta N. Mbong, Stephen B. Kennedy, Razia Laghari, Fiston Nganga, Rigo F. Muhayangabo, Himanshu Vaishnav, Shiromi M. Perera, Andrés Colubri2
, Adam C. Levine2
, and Ian C. Michelow23
Author affiliations: Brown Emergency Medicine, Providence, Rhode Island, USA (A.E. Genisca, H. Vaishnav, A.C. Levine); Alpert Medical School of Brown University, Providence (A.E. Genisca, A.C. Levine, I.C. Michelow); University of Georgia, Athens, Georgia, USA (T.C. Chu); Brown University, Providence (L. Huang, M. Adeniji); Rhode Island Hospital, Providence (M. Gainey); International Medical Corps, Goma, Democratic Republic of the Congo (E.N. Mbong, R. Laghari, F. Nganga, R.F. Muhayangabo); Ministry of Health, Monrovia, Liberia (S.B. Kennedy); International Medical Corps, Washington, DC, USA (S.M. Perera); University of Massachusetts Chan Medical School, Worcester, Massachusetts, USA (A. Colubri)
Figure 5. Prevalence of clinical symptoms for pediatric patients with suspected Ebola virus disease in West Africa, September 2014–September 2015, compared with Democratic Republic of the Congo, 2018–2019.
Page created: April 11, 2022
Page updated: May 22, 2022
Page reviewed: May 22, 2022
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.